Allogeneic Engineered Gingival Fibroblasts (Scarcell Therapeutics)

N/A

Report date: 2025/01/21 17:01:35

Base Information

Drug NameAllogeneic Engineered Gingival Fibroblasts (Scarcell Therapeutics)
Drug Alias NameaeGFAllogeneic engineered gingival fibroblasts cell therapy (Scarcell Therapeutics)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTfs Trial Form Support
China Registration ClassN/A

Develop Information

Active CompaniesTfs Trial Form SupportScarcell Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A